Great example of malnutrition—although in that case there might well be a good argument you are better off funding more RUTF or better malnutrition centers.
I think there’s a real difference in funging risk between your intervention and funding ready-to-use therapeutic food (RUTF) or malnutrition centers.
If we donate to RUTFs or malnutrition centers, some of that may be offset by big NGOs and governments giving a little less. That’s pretty undesirable, given the relatively low value of what many of them would do with the extra money.
If we donate to the nine-month old’s family, there is the possibility that the $100 for transport would have been raised by the family and the surrounding community. But unlike in the NGO/government scenario, your added value in the scenario in which the family/community raised the money is hardly ~zero. There’s now counterfactually $100 more money in the pockets of (presumably) poor individuals, which is a good thing and is probably roughly equivalent to the impact of GiveDirectly distributing $100. Moreover, in that hypothetical, the infant’s family has probably exhausted its financial resources and gone into debt—factors that may reduce the risk of successful aftercare and a good ultimate outcome. So even the scenario where your donation was 100% subject to funging is not such a terrible outcome.
Cancer treatment in Uganda is very poor and expensive. The obvious factor which made situations far less cost-effective even if they were cured were just age, life saving treatment in kids.
My lay understanding is that successful treatment of pediatric cancers often allows for a ~normal lifespan and life, while even initially successful treatment of adult cancers often carries a significant 5-10 year mortality rate[1] and involves significant continuing morbidity (e.g., residual pain, lymphedema). So initial successful treatment of a pediatric cancer seems to be a more good result than initial successful treatment of an adult cancer, even if one disregards years of life saved.
In this case it was actually easier in a way, we were being sent cases of sick people that we never actually told we might helpe, so we didn’t actually have to refuse a personal cry for help.
I think this touches on another probable advantage to your model. I’ve read and heard that Westerners have to be careful doing relief work, lest their actions disrupt the processes the community has developed for mutual aid and support by instead leading everyone to look to the NGO to fix the problem with their money. This problem seems much less likely to develop under your system, as you had no application process to attract candidates, a large catchment area for selecting beneficiaries, and a very low rate of selection.
I’m assuming that most of the cancers identified were not early-stage cancers due to limited levels of medical care and specialized diagnostic equipment.
I think there’s a real difference in funging risk between your intervention and funding ready-to-use therapeutic food (RUTF) or malnutrition centers.
If we donate to RUTFs or malnutrition centers, some of that may be offset by big NGOs and governments giving a little less. That’s pretty undesirable, given the relatively low value of what many of them would do with the extra money.
If we donate to the nine-month old’s family, there is the possibility that the $100 for transport would have been raised by the family and the surrounding community. But unlike in the NGO/government scenario, your added value in the scenario in which the family/community raised the money is hardly ~zero. There’s now counterfactually $100 more money in the pockets of (presumably) poor individuals, which is a good thing and is probably roughly equivalent to the impact of GiveDirectly distributing $100. Moreover, in that hypothetical, the infant’s family has probably exhausted its financial resources and gone into debt—factors that may reduce the risk of successful aftercare and a good ultimate outcome. So even the scenario where your donation was 100% subject to funging is not such a terrible outcome.
My lay understanding is that successful treatment of pediatric cancers often allows for a ~normal lifespan and life, while even initially successful treatment of adult cancers often carries a significant 5-10 year mortality rate[1] and involves significant continuing morbidity (e.g., residual pain, lymphedema). So initial successful treatment of a pediatric cancer seems to be a more good result than initial successful treatment of an adult cancer, even if one disregards years of life saved.
I think this touches on another probable advantage to your model. I’ve read and heard that Westerners have to be careful doing relief work, lest their actions disrupt the processes the community has developed for mutual aid and support by instead leading everyone to look to the NGO to fix the problem with their money. This problem seems much less likely to develop under your system, as you had no application process to attract candidates, a large catchment area for selecting beneficiaries, and a very low rate of selection.
I’m assuming that most of the cancers identified were not early-stage cancers due to limited levels of medical care and specialized diagnostic equipment.